Why the study?
Does vasopressin improve recovery in a patient with catecholamine-resistant vasodilatory shock?
Does vasopressin improve recovery in a patient with catecholamine-resistant vasodilatory shock?
Vasopressin may be a valuable adjunct treatment for reversing catecholamine-resistant vasodilatory shock.
Supports adjunctive vasopressin in refractory vasodilatory shock; hypothesis-generating and should not change practice without RCTs.
A patient with perforated appendicitis developed progressive vasodilatory shock which was complicated by perioperative acute myocardial infarction. Cardiovascular support included dopamine infusion, and later, intra-aortic balloon counterpulsation balloon pump and noradrenaline and dobutamine infusion. Vasopressin was introduced as a final attempt to reverse the refractory shock and was associated with recovery. The experience with this case suggests that vasopressin may be a valuable adjunct to the treatment of catecholamine-resistant vasodilatory shock.
No takes yet. Share an insight, caveat, or question.
Lim et al. (2000) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: